These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 20190962)

  • 21. Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Lee CC; Chang CP; Lin CJ; Lai HL; Kao YH; Cheng SJ; Chen HM; Liao YP; Faivre E; Buée L; Blum D; Fang JM; Chern Y
    Mol Neurobiol; 2018 Dec; 55(12):8936-8952. PubMed ID: 29616397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of adenosine A
    Garcia CP; Licht-Murava A; Orr AG
    Int Rev Neurobiol; 2023; 170():121-154. PubMed ID: 37741689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulating Alzheimer's disease through caffeine: a putative link to epigenetics.
    Marques S; Batalha VL; Lopes LV; Outeiro TF
    J Alzheimers Dis; 2011; 24 Suppl 2():161-71. PubMed ID: 21427489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential of Caffeine in Alzheimer's Disease-A Review of Experimental Studies.
    Londzin P; Zamora M; Kąkol B; Taborek A; Folwarczna J
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33562156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.
    Laurent C; Burnouf S; Ferry B; Batalha VL; Coelho JE; Baqi Y; Malik E; Mariciniak E; Parrot S; Van der Jeugd A; Faivre E; Flaten V; Ledent C; D'Hooge R; Sergeant N; Hamdane M; Humez S; Müller CE; Lopes LV; Buée L; Blum D
    Mol Psychiatry; 2016 Jan; 21(1):97-107. PubMed ID: 25450226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice.
    Cao C; Cirrito JR; Lin X; Wang L; Verges DK; Dickson A; Mamcarz M; Zhang C; Mori T; Arendash GW; Holtzman DM; Potter H
    J Alzheimers Dis; 2009; 17(3):681-97. PubMed ID: 19581723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of adenosine A
    Silva AC; Lemos C; Gonçalves FQ; Pliássova AV; Machado NJ; Silva HB; Canas PM; Cunha RA; Lopes JP; Agostinho P
    Neurobiol Dis; 2018 Sep; 117():72-81. PubMed ID: 29859867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice.
    Cao C; Wang L; Lin X; Mamcarz M; Zhang C; Bai G; Nong J; Sussman S; Arendash G
    J Alzheimers Dis; 2011; 25(2):323-35. PubMed ID: 21422521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of adenosine A
    Li XC; Hong FF; Tu YJ; Li YA; Ma CY; Yu CY; Fang L; Chen JY; Li ZL; Bao SJ; Zhang ZL; Ying HY; Gyabaah AT; Hu SY; Shao GH; Cai XH
    Exp Neurol; 2022 Apr; 350():113929. PubMed ID: 34813840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: a rodent model of attention-deficit hyperactivity disorder.
    Pires VA; Pamplona FA; Pandolfo P; Fernandes D; Prediger RD; Takahashi RN
    Behav Pharmacol; 2009 Mar; 20(2):134-45. PubMed ID: 19307960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Avenanthramide-C Restores Impaired Plasticity and Cognition in Alzheimer's Disease Model Mice.
    Ramasamy VS; Samidurai M; Park HJ; Wang M; Park RY; Yu SY; Kang HK; Hong S; Choi WS; Lee YY; Kim HS; Jo J
    Mol Neurobiol; 2020 Jan; 57(1):315-330. PubMed ID: 31332763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Istradefylline reduces memory deficits in aging mice with amyloid pathology.
    Orr AG; Lo I; Schumacher H; Ho K; Gill M; Guo W; Kim DH; Knox A; Saito T; Saido TC; Simms J; Toddes C; Wang X; Yu GQ; Mucke L
    Neurobiol Dis; 2018 Feb; 110():29-36. PubMed ID: 29100987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
    Gao J; Wang L; Gao C; Arakawa H; Perry G; Wang X
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165580. PubMed ID: 31678156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of cannabinoid signaling in microglia by adenosine A
    Franco R; Reyes-Resina I; Aguinaga D; Lillo A; Jiménez J; Raïch I; Borroto-Escuela DO; Ferreiro-Vera C; Canela EI; Sánchez de Medina V; Del Ser-Badia A; Fuxe K; Saura CA; Navarro G
    Glia; 2019 Dec; 67(12):2410-2423. PubMed ID: 31429130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
    Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
    Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice.
    Arendash GW; Mori T; Cao C; Mamcarz M; Runfeldt M; Dickson A; Rezai-Zadeh K; Tane J; Citron BA; Lin X; Echeverria V; Potter H
    J Alzheimers Dis; 2009; 17(3):661-80. PubMed ID: 19581722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to β-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment.
    Ostapchenko VG; Chen M; Guzman MS; Xie YF; Lavine N; Fan J; Beraldo FH; Martyn AC; Belrose JC; Mori Y; MacDonald JF; Prado VF; Prado MA; Jackson MF
    J Neurosci; 2015 Nov; 35(45):15157-69. PubMed ID: 26558786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronal histamine and cognitive symptoms in Alzheimer's disease.
    Zlomuzica A; Dere D; Binder S; De Souza Silva MA; Huston JP; Dere E
    Neuropharmacology; 2016 Jul; 106():135-45. PubMed ID: 26025658
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.